ArticleReproduction & fertility2025
Global trends and collaboration in ovarian tissue transplantation: a 20-year bibliometric analysis.
Article in Reproduction & fertility, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abstract: Ovarian tissue transplantation is vital for preserving fertility in female cancer survivors. Since the first human ovarian tissue transplantation in 2000 and the first live birth in 2004, it has received much more attention. However, the research scale, core research teams, and publication quality have not been systematically documented. This lack of foundational data hinders researchers' ability to assess the maturity and prevailing trends within the domain, potentially leading to duplicated efforts and suboptimal resource allocation. Our study addresses this gap by analyzing ovarian tissue transplantation research from 2000 to 2023 to map academic performance and collaboration networks. Key findings reveal Belgium and the USA as leading contributors, with robust international collaboration driving progress. The Université Catholique Louvain emerged as the most productive institution, while Dolmans M.M. stood out as a pivotal researcher. Human Reproduction ranked as the top journal for disseminating OTT advancements. Research trends highlight sustained focus on 'tissue cryopreservation', 'activation', and 'live-birth' through 2023, with disease indications shifting from 'breast cancer' and 'chemotherapy' toward 'infertility', 'leukemia', and 'premature ovarian failure'. This study offers crucial insights and understanding for collaborative work among researchers in the field of ovarian tissue transplantation, as well as recommendations for pioneering authors and journal submissions. Lay summary: Ovarian tissue transplantation is the sole fertility preservation method for prepubertal girls and adult female patients whose anticancer therapy cannot be delayed. Since the first successful human live birth via ovarian tissue transplantation in 2004, this medical procedure has witnessed exponential growth, with more than 200 newborns worldwide having been delivered. This study presents an exhaustive bibliometric analysis that delineates the knowledge structure, authors' contributions, and research trends concerning ovarian tissue transplantation during the 21st century. We reveal that Belgium and the USA are in leading positions in terms of publications, citations, and academic influence. Keywords highlight the developmental trends in research types, ongoing foci, and disease indications for ovarian tissue transplantation. It offers crucial insights and understanding for collaborative work among researchers in the field of ovarian tissue transplantation, as well as recommendations for pioneering authors and journal submissions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.